Sai Life Science Share Price

1,784.60190.10 (11.93%)

Live
As On: 06 Nov, 2026, 01:05 PM IST
As On: 06 Nov, 2026, 01:05 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Open	1,655.10
High	1,795.00
Low	1,614.90
Prev Close	1,594.50
Volume	80,57,340
VWAP(₹)	1,754.72

Share Price	Value
Today/Current/Last	1,784.601,784.00
Previous Day	1,594.501,596.20

Sai Life Science Share Recommendations

Mean recosCurrent

STRONG BUY

5 Analysts

Strong
SellSellHoldBuyStrong
Buy

Analyst Trends

Ratings	Current	1W Ago	1M Ago	3M Ago
Strong Buy	3	3	3	3
Buy	2	2	2	2
Hold	-	-	-	-
Sell	-	-	-	-
Strong Sell	-	-	-	-
# Analysts	5	5	5	5

View all Stock Recommendations

News & Analysis

View all Sai Life Science Share News & Announcements

Financials

Income (P&L)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Total Income	557.83	617.66	564.84	552.80	506.32
Total Income Growth (%)	-9.69	9.35	2.18	9.18	-14.05
Total Expenses	452.22	470.61	420.98	431.39	413.21
Total Expenses Growth (%)	-3.91	11.79	-2.41	4.40	-10.06
EBIT	105.61	147.05	143.87	121.40	93.11
EBIT Growth (%)	-28.18	2.22	18.50	30.38	-28.20
Profit after Tax (PAT)	73.29	104.24	100.38	83.84	60.46
PAT Growth (%)	-29.69	3.85	19.72	38.69	-31.51
EBIT Margin (%)	18.93	23.81	25.47	21.96	18.39
Net Profit Margin (%)	13.14	16.88	17.77	15.17	11.94
Basic EPS (₹)	3.46	4.93	4.77	4.01	2.90

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Total Income	550.27	610.09	557.63	541.60	493.04
Total Income Growth (%)	-9.80	9.41	2.96	9.85	-14.52
Total Expenses	448.96	467.07	419.10	423.03	404.37
Total Expenses Growth (%)	-3.88	11.45	-0.93	4.62	-9.58
EBIT	101.32	143.02	138.53	118.57	88.68
EBIT Growth (%)	-29.16	3.24	16.84	33.71	-31.59
Profit after Tax (PAT)	71.34	102.53	97.63	82.95	58.37
PAT Growth (%)	-30.42	5.02	17.70	42.11	-35.10
EBIT Margin (%)	18.41	23.44	24.84	21.89	17.99
Net Profit Margin (%)	12.96	16.81	17.51	15.32	11.84
Basic EPS (₹)	3.36	4.85	4.64	3.97	2.80

	FY 2026	FY 2025	FY 2024	FY 2023
Total Revenue	2,241.62	1,731.35	1,494.27	1,245.11
Total Revenue Growth (%)	29.47	15.87	20.01	38.69
Total Expenses	1,767.43	1,503.65	1,385.04	1,228.70
Total Expenses Growth (%)	17.54	8.56	12.72	38.36
Profit after Tax (PAT)	348.91	170.13	82.81	9.99
PAT Growth (%)	105.08	105.45	729.00	60.44
Operating Profit Margin (%)	23.41	17.93	13.31	7.67
Net Profit Margin (%)	15.91	10.03	5.65	0.82
Basic EPS (₹)	16.63	8.83	4.57	0.55

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	2,202.36	1,679.38	1,448.01	1,185.36	869.17
Total Revenue Growth (%)	31.14	15.98	22.16	36.38	11.61
Total Expenses	1,738.18	1,447.67	1,319.01	1,152.68	846.82
Total Expenses Growth (%)	20.07	9.75	14.43	36.12	22.52
Profit after Tax (PAT)	341.48	173.46	95.23	24.24	15.68
PAT Growth (%)	96.86	82.15	292.92	54.55	-75.99
Operating Profit Margin (%)	23.07	18.37	14.71	8.92	8.30
Net Profit Margin (%)	15.85	10.56	6.71	2.09	1.86
Basic EPS (₹)	16.27	9.00	52.57	13.42	8.97

All figures in Rs Cr, unless mentioned otherwise

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 29.47% outperformed its 3 year CAGR of 21.41%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 1.79% of its operating revenues towards interest expenses and 31.15% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

View Details

Balance Sheet

Annual	FY 2026	FY 2025	FY 2024	FY 2023
Total Assets	3,626.14	3,159.98	2,275.14	2,186.65
Total Assets Growth (%)	14.75	38.89	4.05	1.04
Total Liabilities	1,142.45	1,031.62	1,299.99	1,298.56
Total Liabilities Growth (%)	10.74	-20.64	0.11	1.00
Total Equity	2,483.69	2,128.35	974.76	887.71
Total Equity Growth (%)	16.70	118.35	9.81	1.08
Current Ratio (x)	1.69	2.05	1.28	1.27
Total Debt to Equity (x)	0.04	0.06	0.73	0.79
Contingent Liabilities	450.95	160.95	91.49	75.06

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	3,602.82	3,136.66	2,239.92	2,130.62	2,105.89
Total Assets Growth (%)	14.86	40.03	5.13	1.17	15.93
Total Liabilities	1,094.85	969.20	1,228.72	1,217.89	1,214.86
Total Liabilities Growth (%)	12.96	-21.12	0.89	0.25	28.02
Total Equity	2,507.97	2,167.46	1,010.81	912.35	890.65
Total Equity Growth (%)	15.71	114.43	10.79	2.44	2.71
Current Ratio (x)	1.66	2.06	1.32	1.29	1.33
Total Debt to Equity (x)	0.04	0.06	0.70	0.77	0.84
Contingent Liabilities	450.95	164.66	83.21	66.78	48.28

All figures in Rs Cr, unless mentioned otherwise

View Details

Cash Flows

Annual	FY 2026	FY 2025	FY 2024	FY 2023
Net Cash flow from Operating Activities	509.13	314.05	263.09	219.40
Net Cash used in Investing Activities	-395.41	-536.67	-192.38	-101.78
Net Cash flow from Financing Activities	-123.68	301.43	-95.30	-200.65
Net Cash Flow	-9.14	79.08	-23.56	-80.25
Closing Cash & Cash Equivalent	81.91	91.05	11.97	35.53
Closing Cash & Cash Equivalent Growth (%)	-10.04	660.73	-66.31	-69.31
Total Debt/ CFO (x)	0.19	0.41	2.70	3.19

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	495.27	330.35	250.64	221.47	88.38
Net Cash used in Investing Activities	-392.71	-564.71	-190.05	-111.23	-94.63
Net Cash flow from Financing Activities	-109.23	314.31	-84.63	-190.04	80.95
Net Cash Flow	-6.52	79.95	-24.04	-79.80	74.70
Closing Cash & Cash Equivalent	78.60	85.12	5.17	29.21	109.01
Closing Cash & Cash Equivalent Growth (%)	-7.66	1,545.54	-82.29	-73.20	217.72
Total Debt/ CFO (x)	0.19	0.39	2.83	3.16	8.50

All figures in Rs Cr, unless mentioned otherwise

Insights

Decrease in Cash from Investing
Company has used Rs 395.41 cr for investing activities which is an YoY decrease of 26.32%. (Source: Consolidated Financials)

View Details

Ratios

Annual	FY 2026	FY 2025	FY 2024	FY 2023
Return on Equity (%)	14.04	7.99	8.49	1.12
Return on Capital Employed (%)	18.38	12.51	12.71	6.54
Return on Assets (%)	9.62	5.38	3.63	0.45
Interest Coverage Ratio (x)	17.34	5.81	3.66	2.50
Asset Turnover Ratio (x)	0.65	0.62	0.66	0.56
Price to Earnings (x)	59.17	93.46	-	-
Price to Book (x)	8.28	7.46	-	-
EV/EBITDA (x)	30.19	35.14	-	-
EBITDA Margin (%)	31.02	26.10	21.47	15.84

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	13.61	8.00	9.42	2.65	1.76
Return on Capital Employed (%)	17.99	12.52	13.76	7.42	4.99
Return on Assets (%)	9.47	5.53	4.25	1.13	0.74
Interest Coverage Ratio (x)	19.90	6.11	3.96	2.71	3.15
Asset Turnover Ratio (x)	0.64	0.61	0.65	0.55	0.43
Price to Earnings (x)	60.24	91.74	-	-	-
Price to Book (x)	8.20	7.33	-	-	-
EV/EBITDA (x)	31.65	36.36	-	-	-
EBITDA Margin (%)	30.14	26.05	22.27	16.51	17.78

Insights

ROE Outperforming 5 Year Average
Company delivered ROE of 14.04% in year ending Mar 31, 2026 outperforming its 5 year avg. of 8.41%. (Source: Consolidated Financials)

Found Financials useful?

5 Days	14 Days	28 Days
52.84	51.45	50.40

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Sai Life Science Ltd.	104.70	15.25	14.04	18.38	9.62	21.41	23.41	15.91	16.63	1.69	0.04	0.19
Ipca Labs	34.94	5.14	14.15	17.23	9.22	15.36	17.98	12.35	46.94	2.76	0.09	0.62
Emcure Pharmaceuticals Ltd.	38.50	8.46	18.67	25.65	9.61	15.02	15.88	10.22	48.77	1.43	0.24	1.28
Ajanta Pharma	32.73	9.13	23.32	29.40	17.15	13.41	25.56	19.36	84.53	2.64	0.05	0.40
Piramal Pharma	-151.97	3.89	-3.99	2.29	-1.81	7.44	3.42	-4.31	-2.46	1.51	0.67	3.33
Add More

Annual Ratios (%)

Choose from Peers

Wockhardt
Rubicon Research Ltd.
Neuland Labs
Granules India
Caplin Point

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Sai Life Science Ltd. Stock Performance	12.07	14.72	14.68	26.41	93.73	0.00	0.00
Ipca Labs Stock Performance	-0.76	0.37	-0.54	11.57	48.29	96.51	81.36
Emcure Pharmaceuticals Ltd. Stock Performance	-0.85	18.92	15.79	14.94	63.80	0.00	0.00
Ajanta Pharma Stock Performance	0.94	-5.59	-7.29	-4.54	28.96	82.29	127.08
Piramal Pharma Stock Performance	0.02	-0.10	19.03	14.61	19.74	119.97	0.00
Add More

Category	No. of Shares	Percentage	% Change QoQ
Promoters	7,32,94,675	34.50 %	-0.03
Pledge	0	0.00 %	0.00
FII	4,22,96,927	19.91 %	0.25
DII	6,86,61,661	32.32 %	-0.39
MF	6,27,96,845	29.56 %	0.08
Others	2,81,64,953	13.27 %	0.16

Category	Sep 2026	Jun 2026	Mar 2026	Dec 2025
Promoters	34.50	34.53	34.61	34.70
Pledge	0.00	0.00	0.00	0.00
FII	19.91	19.65	21.17	21.41
DII	32.32	32.71	31.54	31.41
Mutual Funds	29.56	29.47	27.80	27.57
Others	13.27	13.11	12.68	12.48

Mutual Funds Ownership

MF Ownership as on 30 September 2026

Nippon India Small Cap Direct-G
Equity: Small Cap
4
- 1,000.66
  Amount Invested (in Cr.)
- 1.24%
  % of AUM
- 0.00
  % Change (MoM basis)
Invesco India Small Cap Direct-G
Equity: Small Cap
5
- 829.42
  Amount Invested (in Cr.)
- 5.14%
  % of AUM
- 0.00
  % Change (MoM basis)
Invesco India Large & Mid Cap Direct-G
Equity: Large & MidCap
5
- 653.07
  Amount Invested (in Cr.)
- 5.36%
  % of AUM
- 0.00
  % Change (MoM basis)

View all Mutual Fund Schemes

Corporate Actions

Recent
Board Meeting
Quarterly Results
Oct 01, 2026
General Meeting
-
Aug 21, 2026
Board Meeting
Quarterly Results
Jul 01, 2026

Board Meetings

Announced on	Meeting on
Oct 01, 2026	Nov 05, 2026
Quarterly Results
Jul 01, 2026	Aug 06, 2026
Quarterly Results
Apr 21, 2026	May 14, 2026
Audited Results
Jan 22, 2026	Feb 05, 2026
Quarterly Results
Oct 24, 2025	Nov 06, 2025
Quarterly Results

Dividends
No Data Available
Bonus
No Data Available
Splits
No Data Available
Rights
No Data Available
AGM/EGM Meetings
Announced on Meeting on
Aug 21, 2026 Sep 17, 2026
-
Aug 18, 2025 Sep 11, 2025
-
May 15, 2025 May 18, 2025
-

Announced on	Meeting on
Aug 21, 2026	Sep 17, 2026
-
Aug 18, 2025	Sep 11, 2025
-
May 15, 2025	May 18, 2025
-

About Sai Life Science

Sai Life Science Ltd., incorporated in the year 1999, is a Small Cap company (having a market cap of Rs 33,870.08 Crore) operating in Pharmaceuticals sector.

Sai Life Science Ltd. key Products/Revenue Segments include Pharmaceutical Products, Other Operating Revenue and Export Incentives for the year ending 31-Mar-2025.

For the quarter ended 30-06-2026, the company has reported a Consolidated Total Income of Rs 557.83 Crore, down 9.69 % from last quarter Total Income of Rs 617.66 Crore and up 10.17 % from last year same quarter Total Income of Rs 506.32 Crore. Company has reported net profit after tax of Rs 73.28 Crore in latest quarter.

The company’s top management includes Dr.Kanumuri Ranga Raju, Mr.Krishnam Raju Kanumuri, Mr.Sivaramakrishnan Chittor, Dr.Dinesh V Patel, Dr.Ramesh Ganesh Iyer, Ms.Suchita Sharma, Ms.Runa Karan. Company has Deloitte Haskins & Sells LLP as its auditors. As on 30-09-2026, the company has a total of 21.24 Crore shares outstanding.

Sai Life Science Share Price Today is Rs. 1784.60. On previous day, the Sai Life Science Share Price (NSE) closed at Rs. 1546.1, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 30th Sep, 2026, the promoter held 34.5% of the stake in Sai Life Science shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Sai Life Science stocks was 19.91% as compared to 19.65% in Jun 2026 with increase of 0.26%. The domestic institutional investors (DII) holdings on 30th Sep, 2026 was 32.32% as compared to 32.71% in Jun 2026 with decrease of 0.39%. Out of the total DII holdings in Sai Life Science shares 29.56% was held by mutual funds. The rest including public held is 13.27%. Sai Life Science stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Sai Life Science Dividend: The company has not paid any dividend so far. The Earnings Per Share (EPS) for quarter ending 30th Jun 2026 is Rs. 17.03.

Stock Forecast:
After showing 557.83 Cr. of sales and 9.69% of quarterly net loss, there have been multiple ups and downs in the Sai Life Science stock prices in the past few weeks. For example, Sai Life Science stock price on 29th of October 2026 was around Rs. 1495.7. Sai Life Science share price now stands at an average of Rs. 1784.60. Judging by last week's performance, stock is in up trend.

Sai Life Science has a median target price of Rs. 1563.2 in 12 months by 5 analysts. They have provided a high estimate of Rs. 1610.0 and low estimate of Rs. 1450.0 for Sai Life Science share.

Historical Prices and Performance:
Sai Life Science, incorporated in 1999 is a Mid Cap company (with a market cap of Rs. 33914.89) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Sai Life Science stock was 14.04%, 7.99%, 8.49%, 1.12% and 0.7% respectively.

Key Metrics:
PE Ratio of Sai Life Science is 93.63
Prices/Sales Ratio of Sai Life Science is 9.37
Price/Book Ratio of Sai Life Science is 13.64

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Sai Life Science, major competitors and peers include Emcure Pharmaceuticals Ltd., Ajanta Pharma, Wockhardt and Piramal Pharma. As of Jun 2026, the dividend yield of Sai Life Science stands at 0.0% while Emcure Pharmaceuticals Ltd., Ajanta Pharma, Wockhardt and Piramal Pharma stand at 0.16%, 0.85%, 0.0% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 93.63 and 13.64 respectively.

Leadership of Sai Life Science :
Runa Karan is Co. Secretary & Compl. Officer
Kanumuri Ranga Raju is Chairman & Wholetime Director
Krishnam Raju Kanumuri is Managing Director & CEO
Sivaramakrishnan Chittor is WholeTime Director & CFO
Suchita Sharma is Independent Director
Ramesh Ganesh Iyer is Independent Director
Dinesh V Patel is Independent Director

Industry

Pharma - Indian

Key Indices Listed On

Nifty Smallcap 100, Nifty 500, BSE 500, Nifty Pharma, BSE 250 SmallCap Index

Address

Plot No. DS- 7, IKP Knowledge Park,Turkapally Village, Shameerpet Mandal,Medchal - Malkajgiri District,Hyderabad, Telangana - 500078

Contact

investors@sailife.com

http://www.sailife.com

PE Ratio(x)	104.70
EPS - TTM(₹)	17.03
MCap(₹ Cr.)	37,725.48
MCap Rank	22
PB Ratio(x)	13.64
Div Yield(%)	-
Face Value(₹)	1.00
52W High(₹)	1,795.00
52W Low(₹)	783.85
MCap/Sales	9.37
Beta(1 Month)	-
BV/Share(₹)	116.92

PE Ratio(x)	104.62
EPS - TTM(₹)	17.03
MCap(₹ Cr.)	37,999.49
MCap Rank	22
PB Ratio(x)	13.65
Div Yield(%)	-
Face Value(₹)	1.00
52W High(₹)	1,795.00
52W Low(₹)	786.15
MCap/Sales	9.37
Beta(1 Month)	-
BV/Share(₹)	116.92

1 Day	11.93%
1 Month	14.54%
3 Months	26.25%
1 Year	93.49%
3 Years	N.A.
5 Years	N.A.

1 Day	11.76%
1 Month	14.59%
3 Months	26.06%
1 Year	93.47%
3 Years	N.A.
5 Years	N.A.

R1	1612.80	Pivot 1580.70	S1	1562.40
R2	1631.10		S2	1530.30
R3	1681.50		S3	1479.90

Sai Life Science Share Price

Key Metrics